Tower Research Capital (TRC)’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-19
Closed -$195 – 6458
2023
Q2
$195 Sell
19
-85
-82% -$867 ﹤0.01% 5748
2023
Q1
$1K Buy
+104
New +$1.05K ﹤0.01% 5711
2022
Q1
– Sell
-883
Closed -$9K – 6856
2021
Q4
$9K Sell
883
-202
-19% -$1.98K ﹤0.01% 4750
2021
Q3
$11K Buy
+1,085
New +$10.7K ﹤0.01% 4278

Tower Research Capital (TRC)'s DALS Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 19 shares — an estimated $195 sold.

Tower Research Capital (TRC) first reported a position in DALS in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 19 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $195.
  • Tower Research Capital (TRC) first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s DA32 Life Science Tech Acquisition Corp position peaked at $11K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.